Photoacoustic catheter for functional-imaging-based ablation monitoring

Patent metadata

Field	Value
Publication number	US-9743881-B2
Application number	US-201214007029-A
Country	US
Kind code	B2
Filing date	Mar 27, 2012
Priority date	Mar 29, 2011
Publication date	Aug 29, 2017
Grant date	Aug 29, 2017

Abstract

Functional imaging for localization in biological tissue entails measuring a response in the tissue ( 240 ) to electromagnetic radiation. A catheter ( 200 ) for real-time monitoring of cardiac ablation is employed to distinguish a hemorrhage zone ( 232 ) from the sandwiching necrotic and healthy tissue, or to distinguish exogenous photoacoustic contrast agent from bordering native tissue. A pair of wavelengths is selected for differential absorption ( 244 ) of the radiation in, correspondingly, the hemorrhage zone or where the contrast agent exists, and relatively similar absorption elsewhere. Near infrared laser or LED light may be used photoacoustically to serially acquire (S 310 , S 320 ) the two datasets to be compared, each representative of a time waveform. Alternatively, acquisition is for a pair of wavelength bands of microwave-induced thermoacoustic data. In either case, the members of the dataset pair are combined ( 110, 122 ) by subtraction or division to effect the piece-wise cancellation/enhancement for display ( 218 ) of the resulting signal in real time.

First claim

What is claimed is:

1. An apparatus configured for using functional imaging for localization of biological tissue, said apparatus comprising:
an electromagnetic-radiation emitter configured for emitting electromagnetic radiation to said biological tissue;
an ultrasound transducer configured for receiving ultrasound from said biological tissue responsive to said emitting; and
a photoacoustic imaging device configured for: operating said electromagnetic-radiation emitter; operating said ultrasound transducer; from the received ultrasound, measuring responses in the biological tissue to electromagnetic radiation; and, based on said responses, distinguishing, within the biological tissue, one or both of (i) a hemorrhage zone, disposed between (i)(a) healthy tissue and (i)(b) ablated tissue, from said healthy and ablated tissue by identifying a border between said hemorrhage zone and said healthy tissue and by identifying a border between said hemorrhage zone and said ablated tissue, and (ii) a contrast agent from bordering native tissue,
wherein said distinguishing entails combining, via said photoacoustic imaging device, datasets acquired, via said transducer, by electromagnetic irradiation, via said emitter, at different frequencies or frequency bands,
wherein the datasets serve as measures of absorption by said biological tissue of the electromagnetic radiation, and
wherein the different frequencies or frequency bands are (iii) selected for (iii)(a) differential absorption of radiation in, correspondingly, the hemorrhage zone or where the contrast agent exists and (iii)(b) relatively similar absorption elsewhere in the healthy tissue, the ablated tissue, and the bordering native tissue.

2. The apparatus of claim 1 , wherein said combining of said datasets enhances a data magnitude in said hemorrhage zone relative to that, respectively, for adjacent healthy and ablated tissue.

3. The apparatus of claim 1 , further comprising a display for displaying a signal representative of the combined datasets, wherein said displaying reflects said distinguishing.

4. The apparatus of claim 3 , wherein the apparatus comprises one or more integrated circuits communicatively connected to at least one of said ultrasound transducer for the acquiring of said datasets and said electromagnetic-radiation emitter for said irradiating.

5. The apparatus of claim 1 , wherein said combining forms a combined dataset; and wherein, in the acquiring, data of one of the datasets to be combined in forming said combined dataset is acquired before acquisition, via said transducer, commences for data of another dataset being combined in said forming of said combined dataset.

6. The apparatus of claim 1 , wherein said combining combines a pair of said datasets, and wherein one of said datasets of said pair is a dataset of a frequency or a frequency band, and wherein the other of said datasets of said pair is respectively of a frequency or of a frequency band, such that said datasets of said pair are both of respective frequencies that differ or both of respective frequency bands that differ.

7. The apparatus of claim 6 , further wherein said combining of said pair of said datasets comprises at least one of subtraction and division.

8. The apparatus of claim 6 , further wherein each of said datasets of said pair is representable as a time waveform.

9. The apparatus of claim 7 , wherein said photoacoustic imaging device is configured for at least one of the subtracting to yield a difference signal and the dividing to yield a quotient signal, the apparatus further comprising
a display, wherein said photoacoustic imaging device is configured for, via said display, displaying at least one of said difference and quotient signal, respectively.

10. The apparatus of claim 6 , further wherein said combining of said pair of datasets is performed by subtraction.

11. The apparatus of claim 1 , wherein said localization includes monitoring, at least via said measuring and said distinguishing, of the biological tissue performed in real time.

12. The apparatus of claim 11 , further wherein said monitoring entails monitoring of cardiac ablation.

13. The apparatus of claim 1 , further wherein said photoacoustic imaging device is further configured for performing a depth-independent equalization that takes into account wavelength-dependent attenuation in said hemorrhage zone.

14. The apparatus of claim 1 , further comprising a catheter that houses said ultrasound transducer.

15. The apparatus of claim 1 , wherein said ablated tissue immediately adjoins said hemorrhage zone to form said border that exists between said hemorrhage zone and said ablated tissue and that defines an outer extent of both said ablated tissue and said hemorrhage zone, and wherein said healthy tissue immediately adjoins said hemorrhage zone to form said border that exists between said hemorrhage zone and said healthy tissue and that defines an outer extent of both said healthy tissue and said hemorrhage zone.

16. The apparatus of claim 1 , wherein said contrast agent comprises methylene blue dye.

17. The apparatus of claim 11 , further comprising a display, and an ablation device for ablating said biological tissue, said apparatus being configured for said distinguishing of said hemorrhage zone and for performing, via said ablation device, ablation to result in said ablated tissue, wherein said photoacoustic imaging device is further configured for, during said ablation, displaying, via said display, updated in real time to reflect said monitoring, a real-time spatial representation of, collectively, said hemorrhage zone adjoined both by said healthy tissue and said ablated tissue.

18. The apparatus of claim 11 , further comprising an ablation device, said apparatus being configured for structural imaging and for said distinguishing of said hemorrhage zone, said apparatus being further configured for performing, via said ablation device, ablation to result in said ablated tissue, wherein said apparatus is further configured for, automatically, without need for user intervention, halting said ablation in real-time response to said border between said hemorrhage zone and said healthy tissue reaching, during said monitoring, in accordance with said structural imaging, a depth at which ablation is to be halted.

19. The apparatus of claim 1 , wherein said biological tissue comprises cardiac tissue, and wherein said responses are measured, by said measuring, in cardiac tissue.

20. A method for using functional imaging for localization of biological tissue, said method comprising:
emitting, via an electromagnetic-radiation emitter, electromagnetic radiation to interrogate biological tissue;
via an ultrasound transducer, receiving, from said biological tissue, responses to the emitted electromagnetic radiation which are elicited by the interrogation;
measuring, via a processor, said responses; and,
via said processor, based on said responses, distinguishing, within the biological tissue, one or both of (i) a hemorrhage zone, disposed between (i)(a) healthy tissue and (i)(b) ablated tissue, from said healthy and ablated tissue by identifying a border between said hemorrhage zone and said healthy tissue and by identifying a border between said hemorrhage zone and said ablated tissue. and (ii) a photoacoustic contrast agent from bordering native tissue, based upon the responses,
wherein said distinguishing entails combining, via the processor, datasets acquired, via said transducer, by said electromagnetic irradiat

Assignees

• Radulescu Emil
• Huang Sheng-Wen
• Erkamp Ramon
• Jankovic Ladislav
• Shi Yan
• Shahzad Khalid
• Koninklijke Philips Nv

Inventors

• Radulescu Emil
• Huang Sheng-Wen
• Erkamp Ramon
• Jankovic Ladislav
• Shi Yan
• Shahzad Khalid

Classifications

• A61B2576/00

  Medical imaging apparatus involving image processing or analysis (A61B1/00009, A61B6/52 and A61B8/52 take precedence) · CPC title

• A61K49/0002

  General or multifunctional contrast agents, e.g. chelated agents · CPC title

• A61B2090/378

  using ultrasound · CPC title

• A61B2018/00577

  Ablation · CPC title

• A61B5/742

  using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339) · CPC title